Secondary Logo

Institutional members access full text with Ovid®

Formal Thought Disorder” in a General-Community Sample With Elevated Schizotypal Traits

Deyo, Cliff, DPsych*; Langdon, Robyn, PhD

The Journal of Nervous and Mental Disease: May 2019 - Volume 207 - Issue 5 - p 410–416
doi: 10.1097/NMD.0000000000000991
Original Articles
Buy
SDC

Different dimensions of formal thought disorder (FTD) are distinguished by different patterns of cognitive dysfunction and cortical variability in patients with schizophrenia; however, inconsistent findings may relate to patient-related confounds. Investigating FTD in nonpatient samples with elevated levels of schizotypal traits avoids these confounds, but its utility to FTD research is unknown. Thus, we performed principal components analysis (PCA) of FTD ratings using the Scale for the Assessment of Thought, Language, and Communication (TLC) and the Thought and Language Index (TLI) in a general-community sample with elevated schizotypal traits. Both scales showed “clinically elevated” FTD, particularly, the TLC. PCA described a three-component TLC solution (“disorganization,” “verbosity,” “emptiness”) and a two-component TLI solution (“negative,” “idiosyncratic”), generally consistent with schizophrenia research. TLC “disorganization” and “emptiness” were correlated with psychosis-like experiences. TLI “negative” was associated with lower general cognitive function, consistent with schizophrenia research. FTD may have shared etiology along the schizophrenia spectrum.

*Department of Psychology, and

ARC Centre of Excellence in Cognition and Its Disorders, Department of Cognitive Science, Macquarie University, Sydney, New South Wales, Australia.

Send reprint requests to Cliff Deyo, DPsych, Department of Psychology, Macquarie University, New South Wales 2109, Australia. E-mail: cdeyo@vt.uniting.org.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.jonmd.com).

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.